| 0 (0%) | 11-11 17:42 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 63.69 | 1-year : | 74.39 |
| Resists | First : | 54.53 | Second : | 63.69 |
| Pivot price | 53.99  |
|||
| Supports | First : | 49.2 |
Second : | 45.9 |
| MAs | MA(5) : | 54.07 |
MA(20) : | 53.93 |
| MA(100) : | 49.99 |
MA(250) : | 44.3 |
|
| MACD | MACD : | 1.1  |
Signal : | 1.3 |
| %K %D | K(14,3) : | 81.6 |
D(3) : | 72.2 |
| RSI | RSI(14): 69 |
|||
| 52-week | High : | 58.4 | Low : | 21.34 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ AKRO ] has closed below upper band by 15.6%. Bollinger Bands are 88.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 54.37 - 54.57 | 54.57 - 54.78 |
| Low: | 53.53 - 53.78 | 53.78 - 54.04 |
| Close: | 53.84 - 54.23 | 54.23 - 54.62 |
Mon, 10 Nov 2025
Akero Therapeutics (AKRO): Examining Valuation After Strong Year-to-Date Share Price Gains - Yahoo Finance
Mon, 10 Nov 2025
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS - PR Newswire
Mon, 10 Nov 2025
Is AKRO stock ready for a breakout - Portfolio Value Report & Growth Focused Entry Reports - newser.com
Sat, 08 Nov 2025
Exit strategy if you’re trapped in AKRO - CEO Change & Fast Momentum Stock Entry Tips - newser.com
Sat, 08 Nov 2025
Akero Therapeutics (NASDAQ:AKRO) Releases Quarterly Earnings Results - MarketBeat
Sat, 08 Nov 2025
Evaluating Akero Therapeutics (AKRO): Is the Current Valuation Justified After Recent Share Price Momentum? - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 80 (M) |
| Shares Float | 63 (M) |
| Held by Insiders | 1.1 (%) |
| Held by Institutions | 118.1 (%) |
| Shares Short | 5,810 (K) |
| Shares Short P.Month | 9,090 (K) |
| EPS | -3.81 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 12.84 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -20.4 % |
| Return on Equity (ttm) | -31.2 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -4.02 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -253 (M) |
| Levered Free Cash Flow | -161 (M) |
| PE Ratio | -14.24 |
| PEG Ratio | 0 |
| Price to Book value | 4.22 |
| Price to Sales | 0 |
| Price to Cash Flow | -17.16 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|